Analysis | Metabolite Name | Measured Value | Units | Sex | Severity_Scale | Race | Ethnicity | hasSmokingBeforeCOVID-19 | Time |
---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 0 | Other | Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 0 | White | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 0 | White | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | Black | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | Other | Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | Other | Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | Other | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | Other | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | Other | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | White | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 2 | Black | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 2 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 2 | White | Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 2 | White | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 2 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 3 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 3 | Black | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 3 | White | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Female | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 0 | White | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 1 | Black | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 1 | Other | Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 1 | Other | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 1 | Other | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 1 | Other | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 1 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 1 | White | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 2 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 3 | Other | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 3 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.46183291 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.394736612 | log transformed data | Male | 1 | Other | Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.374688146 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.361110281 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.357453423 | log transformed data | Female | 0 | Other | Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.340374297 | log transformed data | Female | 1 | Black | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.330811427 | log transformed data | Male | 1 | Other | Hispanic | 1 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.329536521 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.324214705 | log transformed data | Female | 1 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.317841818 | log transformed data | Male | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.296142364 | log transformed data | Female | 1 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.294674257 | log transformed data | Female | 2 | Other | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.276825904 | log transformed data | Male | 1 | Other | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.267614592 | log transformed data | Female | 2 | Other | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.260590149 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.258074105 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.25739362 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.255183899 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.24935154 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.24837837 | log transformed data | Female | 3 | Other | Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.243529854 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.23880581 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.238681543 | log transformed data | Male | 1 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.238575398 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.232693875 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.229531871 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.226532799 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.226381814 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.222665076 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.22039603 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.217211726 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.21686392 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.213208806 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.210439409 | log transformed data | Female | 0 | Other | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.209849987 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.205577248 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.202407825 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.201652943 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.201103752 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.20047394 | log transformed data | Female | 1 | White | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.198490953 | log transformed data | Female | 0 | Other | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.19809103 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.192393202 | log transformed data | Female | 2 | Black | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.191055901 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.190788552 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.188652163 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.187853614 | log transformed data | Male | 2 | Black | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.186345805 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.185220631 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.183034995 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.182341251 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.181597435 | log transformed data | Male | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.179075343 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.175854891 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.173730488 | log transformed data | Female | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.173507148 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.171551957 | log transformed data | Male | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.164656637 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.16227068 | log transformed data | Male | 3 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.161611946 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.160072159 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.157688278 | log transformed data | Male | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.157253855 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.15274732 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.151991911 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.149652023 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.148580867 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.148424103 | log transformed data | Female | 0 | White | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.147389199 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.147370929 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.145789731 | log transformed data | Male | 0 | Other | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.144176006 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.14388232 | log transformed data | Male | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.136198465 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.135835946 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.132850087 | log transformed data | Male | 0 | White | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.132184761 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.128873023 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.128047506 | log transformed data | Male | 1 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.12788134 | log transformed data | Male | 1 | Other | Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.127277767 | log transformed data | Male | 3 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.122932482 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.121989087 | log transformed data | Male | 2 | Other | Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.121326339 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.120966374 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.119150043 | log transformed data | Female | 1 | White | Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.118103803 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.117155818 | log transformed data | Female | 1 | Black | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.116941829 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.116731392 | log transformed data | Male | 1 | White | Non-Hispanic | 0 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.116612334 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.116439916 | log transformed data | Male | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.116402342 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.111356266 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | post-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.109467139 | log transformed data | Female | 0 | Black | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.108788225 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.10867678 | log transformed data | Male | 2 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.108545969 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.106783472 | log transformed data | Female | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.103039401 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.102383925 | log transformed data | Male | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.101582903 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.100757593 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.099498808 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.099455539 | log transformed data | Female | 1 | White | Non-Hispanic | 1 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.095401259 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.094526455 | log transformed data | Male | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.091706872 | log transformed data | Female | 1 | Other | Non-Hispanic | 0 | during COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.090932261 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.090400737 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.090102199 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.088982319 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.088825886 | log transformed data | Male | 0 | Other | Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.08828479 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.086845561 | log transformed data | Male | 2 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.086005616 | log transformed data | Male | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.085981221 | log transformed data | Male | 0 | Other | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.085118848 | log transformed data | Female | 0 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.083642879 | log transformed data | Female | 1 | Other | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.081823702 | log transformed data | Male | 1 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.079046925 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.077796814 | log transformed data | Female | 0 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.076661164 | log transformed data | Female | 1 | White | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.074793631 | log transformed data | Male | 0 | White | Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.073369011 | log transformed data | Female | 0 | Black | Non-Hispanic | 0 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.073278387 | log transformed data | Female | 0 | White | Non-Hispanic | 1 | pre-COVID-19 |
Reversed phase NEGATIVE ION MODE | 4-hydroxyphenylacetate | -0.071613902 | log transformed data | Female | 2 | White | Non-Hispanic | 1 | during COVID-19 |
Return to search page